JANUVIA(TM) (sitagliptin phosphate) is coming soon
If approved, JANUVIA would potentially be the first in a new class of oral medications (DPP-4 inhibitors) that enhances the body’s own ability to lower blood sugar (glucose) when it is elevated.
Related posts:
- Clinical Trials – Diabetes Heart Risk Reduced
- MIT Diabetes Device Monitors Glucose With Light
- Feds Warn Of Counterfeit Diabetes Tests
- Blood Glucose Monitoring Market Gets a Bit Crowded
- Total Product Life Cycle for Portable Invasive Blood Glucose Monitoring Systems – Draft Guidance for Industry and FDA Staff



I am taking JANUVIA I just started I will be back